SCHEMBL743613

SCHEMBL743613

COc1cc(O)c(CC=O)c(OC)c1CC(=O)c1c(O)cc(O)cc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
MAPT P10636 4/20 0.50
HPGD P15428 2/20 0.50
GAA P10253 1/20 0.50
CYP19A1 P11511 1/20 0.45
SMPD1 P17405 2/20 0.43
KCNB1 Q14721 1/20 0.42
CYP3A4 P08684 2/20 0.40
PTGS1 P23219 1/20 0.40
DRD3 P35462 1/20 0.40
SLC5A1 P13866 1/20 0.39
SLC5A2 P31639 1/20 0.39
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
SYNJ2 O15056 1/20 0.37
IMPDH2 P12268 1/20 0.37
MAPK1 P28482 1/20 0.37
PIK3CA P42336 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3860745 0.77 CYP3A4 (0.42) MAPTHPGDCYP3A4IMPDH2TDP1
SCHEMBL15266045 0.76 ALOX5 (0.44) IMPDH2
SCHEMBL743276 0.71 ERN1 (0.57) KMT2AMAPTCYP3A4MAPK1
SCHEMBL16166121 0.68 ABCB1 (0.46) MAPTGAACYP3A4PTGS1TDP1
SCHEMBL742431 0.68 SLC28A3 (0.38) MEN1KMT2AHPGDCYP19A1SMPD1
SCHEMBL1245802 0.67 GAA (0.83) MEN1KMT2AMAPTHPGDGAA
SCHEMBL3965268 0.67 GAA (0.83) MEN1KMT2AMAPTHPGDGAA
SCHEMBL29535946 0.67 GAA (0.83) MEN1KMT2AMAPTHPGDGAA
Water SCHEMBL6998437 0.66 SLC28A3 (0.36) MEN1KMT2AHPGDCYP19A1SMPD1
SCHEMBL7187209 0.66 CYP19A1 (0.68) MEN1KMT2AMAPTHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2429292-A1 COMPOUNDS AND COMPOSITIONS COMPRISING CDK INHIBITORS AND METHODS FOR THE TREATMENT OF CANCER Georgia State University Research Foundation, Inc. (US) 2012-03-21 EP disclosed